leadf
logo-loader
AIM:ERGO ETR:2EM FRA:2EM

Ergomed PLC

Receive alerts
Market:
AIM
Market Cap:
£677.13 m
Price
1,385.00 GBX
Change
0.36%
52 weeks high
1571.00
52 weeks low
680.00

In brief

Ergomed PLC provides specialist services to the pharmaceutical industry spanning all phases of clinical development, post-approval pharmacovigilance and medical information.

The company's fast-growing services business includes an industry-leading suite of specialist pharmacovigilance (PV) solutions, integrated under the PrimeVigilance brand and a full range of high-quality clinical research and trial management services under the Ergomed brand (CRO).

Snapshot

  • Ergomed is a fast-growing pharmaceutical services company
  • Company has clinical trial arm and pharmacovigilance business
  • It is running a trial in Italy to help identify treatments for coronavirus

Insight Widest with the analysis, Proactive gives perspectives that others don't.

Businesses do their bit as coronavirus pandemic pulls community together

Burberry has re-purposed its coat factory in Castleford, UK to produce personal protection equipment (PPE)

on 04/24/2020